Latest filing published 22 Mar 2021 for Bellerophon Therapeutics, Inc., €1.8M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
New Mountain Investments II, LLC: trading record in brief
This profile gathers the share dealings of New Mountain Investments II, LLC across 2 companies, led by Deltek, Inc and Bellerophon Therapeutics, Inc. In total, 35 filings cover trades dated from 6 November 2007 to 18 March 2021.
Both buying and selling appear: 25 purchases worth €11.5M, against 4 sales worth €49.8M. Netting one side against the other leaves €38.2M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 6 share grants. Since January 2021: no purchases and 1 sale on the market.
Half of the purchases are above €2,217 and half below.
Most recently, on 22 March 2021, the filings show an open-market sale worth €1.8M in Bellerophon Therapeutics, Inc. The clock since the last published purchase (23 February 2015) now reads 4,276 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to New Mountain Investments II, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 400,000 shares@ US$5.48100.0% of flowCommon StockSEC:0000895345-21-000387:0
- 1,070,166 shares@ US$12.00Common StockSEC:0001104659-15-013150:0Canonical exit: 20 May 2015 (T+90)
- 3,773,883 shares@ US$3.00Common StockSEC:0000895345-09-000482:0
- 65,558 shares@ US$3.00Common StockSEC:0000895345-09-000482:1
- 290,961 shares@ US$3.00Common StockSEC:0000895345-09-000482:2
- 10,445,542 shares@ US$3.00Common StockSEC:0000895345-09-000457:0
- 181,461 shares@ US$3.00Common StockSEC:0000895345-09-000457:1
- 805,345 shares@ US$3.00Common StockSEC:0000895345-09-000457:2
- 9,454 shares@ US$4.468Common StockSEC:0000895345-08-000618:0Canonical exit: 24 Feb 2009 (T+90)
- 164 shares@ US$4.468Common StockSEC:0000895345-08-000618:1Canonical exit: 24 Feb 2009 (T+90)
- 729 shares@ US$4.468Common StockSEC:0000895345-08-000618:2Canonical exit: 24 Feb 2009 (T+90)
- 8,906 shares@ US$5.0107Common StockSEC:0000895345-08-000618:3Canonical exit: 26 Feb 2009 (T+90)
- 155 shares@ US$5.0107Common StockSEC:0000895345-08-000618:4Canonical exit: 26 Feb 2009 (T+90)
- 686 shares@ US$5.0107Common StockSEC:0000895345-08-000618:5Canonical exit: 26 Feb 2009 (T+90)
- 9,454 shares@ US$3.7835Common StockSEC:0000895345-08-000608:0Canonical exit: 22 Feb 2009 (T+90)
- 164 shares@ US$3.7835Common StockSEC:0000895345-08-000608:1Canonical exit: 22 Feb 2009 (T+90)
- 729 shares@ US$3.7835Common StockSEC:0000895345-08-000608:2Canonical exit: 22 Feb 2009 (T+90)
- 9,453 shares@ US$3.8842Common StockSEC:0000895345-08-000608:3Canonical exit: 23 Feb 2009 (T+90)
- 165 shares@ US$3.8842Common StockSEC:0000895345-08-000608:4Canonical exit: 23 Feb 2009 (T+90)
- 729 shares@ US$3.8842Common StockSEC:0000895345-08-000608:5Canonical exit: 23 Feb 2009 (T+90)
- 9,695 shares@ US$3.6898Common StockSEC:0000895345-08-000602:0Canonical exit: 18 Feb 2009 (T+90)
- 168 shares@ US$3.6898Common StockSEC:0000895345-08-000602:1Canonical exit: 18 Feb 2009 (T+90)
- 747 shares@ US$3.6898Common StockSEC:0000895345-08-000602:2Canonical exit: 18 Feb 2009 (T+90)
- 8,118 shares@ US$3.6178Common StockSEC:0000895345-08-000602:3Canonical exit: 19 Feb 2009 (T+90)
- 141 shares@ US$3.6178Common StockSEC:0000895345-08-000602:4Canonical exit: 19 Feb 2009 (T+90)
25 of 35 declarations
